camptothecin has been researched along with Muscular Atrophy, Spinal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Funanage, VL; Gómez-Curet, I; Scavina, M; Wang, W; Wu, CY | 1 |
Dimatteo, D; Funanage, VL; Scavina, M; Wang, W | 1 |
2 other study(ies) available for camptothecin and Muscular Atrophy, Spinal
Article | Year |
---|---|
Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent.
Topics: Apoptosis; Camptothecin; Cells, Cultured; DNA Topoisomerases, Type I; Fibroblasts; Humans; Muscular Atrophy, Spinal; Naphthoquinones; RNA, Small Interfering; Survival of Motor Neuron 1 Protein; Topoisomerase I Inhibitors; Tumor Suppressor Protein p53 | 2009 |
Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin-induced cell death.
Topics: Atrophy; Base Sequence; Biopsy; Camptothecin; Cell Death; Cell Survival; Fibroblasts; Humans; Molecular Sequence Data; Motor Neurons; Muscular Atrophy, Spinal; Nucleic Acid Conformation; RNA; Sequence Deletion; Skin; Telomere; Vitamin K 3 | 2005 |